V4N-59039-98850
4 vaccinations
5 coded responses
42 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 064 / CT
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
-
2021-01-20
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: GoodFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
- 2021-01-28
-
2021-02-04
Survey response — day 21, dose 2MedDRA: SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: GoodFree text: Upper respiratory infection, tested negative for CoVidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
- 2021-02-26
- 2021-04-15
- 2021-07-15
-
2021-10-15
Dose 3 — Pfizer-BioNTech
-
2021-10-16
Survey response — days 1–6 daily, dose 3MedDRA: Throat irritation — Feeling: Good · Site: PainFree text: Scratchy throatMedDRA releases: 2024-11 · check-in free text available
- 2021-10-17
- 2021-10-18
-
2021-10-20
Survey response — days 1–6 daily, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Fatigue or tirednessFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Survey response — days 1–6 daily, dose 3MedDRA: Nasal disorder, Nasopharyngitis — Feeling: GoodFree text: Mild resolving nasal cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-20
- 2021-11-26
- 2022-01-14
- 2022-04-15
-
2022-09-16
Dose 4 — Pfizer-BioNTech
- 2022-09-27
- 2022-10-07
- 2022-10-16
- 2022-10-21
- 2022-10-28
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Nasal congestion
Release 3 — day 21, dose 2
Symptoms: Upper respiratory infection, tested negative for CoVid
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Scratchy throat
Systemic reaction (other): Cold symptoms
Systemic reaction (other): Mild resolving nasal cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Nasal disorder | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release